Advocacy intelligence hub — real-time data for patient organizations
University of Texas Southwestern Medical Center — NA
GATTEX: FDA approved
Treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
GATTEX
Takeda Pharmaceuticals U.S.A., Inc.
GATTEX
(teduglutide [rDNA origin])Orphan drugTakeda Pharmaceuticals U.S.A., Inc.
GLP-2 Analog [EPC]
12.1 Mechanism of Action Teduglutide is an analog of naturally occurring human glucagon-like peptide-2 (GLP-2), a peptide secreted by L-cells of the d...